Acute Pyelonephritis m.arief 01-038

Embed Size (px)

Citation preview

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    1/46

    Acute Pyelonephritis in Children

    M.Arief Rachman 01-038

    Consultant : dr Alfred Siahaan SpA

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    2/46

    BACKGROUND

    Urinary tract infection (UTI) is one of the

    most common bacterial infection in infants.

    The most severe form of UTI is acute

    pyelonephritis, which results in significant

    acute morbidity and may cause permanent

    renal damage.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    3/46

    BACKGROUND

    Published guidelines recommend

    treatment of acute pyelonephritis initially

    with intravenous (IV) therapy followed by

    oral therapy for seven to 14 days though

    there is no consensus on the duration of

    either IV or oral therapy.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    4/46

    DEFINITION

    Urinary tract infection (UTI) is defined as

    the presence of bacteria in urine along

    with symptoms of infection.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    5/46

    Acute pyelonephritis is a potentially

    organ- and/or life-threatening infection that

    characteristically causes some scarring of

    the kidney with each infection and maylead to significant damage to the kidney

    (any given episode), kidney failure.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    6/46

    ETIOLOGY

    Escherichia coliis the most common

    infecting pathogen in children, accounting

    for up to 80 percent of UTIs. Other

    pathogens include Staphylococcus andStreptococcus species, a variety of

    enterobacteria (e.g., Klebsiella, Proteus)

    and, occasionally, Candida albicans.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    7/46

    INTRARENAL REFLUX OF BACTERIA

    IMMUNE RESPONSE COMPLEMENT ACTIVATION

    BACTERIAL ENDOTOXIN

    CHEMOTAXiS

    BACTERIAL KILLING PHAGOCYTOSIS GRANULOCYTE AGGREGATION

    SUPEROXIDE & LYSOZIME RELEASE

    TUBULAR CELL DEATH

    INTERSTITIAL INVASION FOCAL ISHEMIA

    RENAL SCAR

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    8/46

    PATHOGENESIS

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    9/46

    DIAGNOSIS

    CLINICAL PRESENTATION

    URINE CULTURE / URINALYSIS

    IMAGING STUDIES

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    10/46

    CLINICAL PRESENTATION

    Fever

    Flank pain

    Malaise Nausea

    Vomiting

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    11/46

    URINE CULTURESample of urine Colony specimen Infection

    Supra pubic punction Any negative gram

    bacterial

    > 99%

    Cathterized specimen >10 5

    104-105

    103-104

    104

    3x specimen>105

    2x specimen>105

    1x specimen >105

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    12/46

    URINALYSIS

    Gross hematuria

    significant pyuria (>20 WBCs/hpf)

    The dipstick leukocyte esterase test (LET)

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    13/46

    HISTOLOGICAL STUDIES

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    14/46

    HISTOLOGICAL STUDIES

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    15/46

    HISTOLOGICAL STUDIES

    The inflammation can destroy the tubules,forming abscesses. The presence of polysin the tubules is strong evidence of

    possible bacterial infection. Polys are seenin the interstitium/interstitial capillaries aswell.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    16/46

    PIV

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    17/46

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    18/46

    DMSA Renal Scan

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    19/46

    The SPECT technique for 99mTc-DMSA scintigraphy was used tomake it comparable to the other cross-sectional imaging techniques.The images were obtained 23 hours after an intravenous injectionof 99mTc-DMSA in a dose of approximately 3.7 MBq/kg (100Ci/kg).

    The SPECT images were reconstructed in coronal, sagittal, and

    transverse planes by using a Butterworth filter with a frequencycutoff of 0.4 cycles per centimeter.

    The criterion for the diagnosis of acute pyelonephritis was subjectiveevidence of focal areas of decreased uptake seen with at least twoprojections. No attempt was made to quantify the severity ofdecreased uptake (Fig 1a).

    http://radiology.rsnajnls.org/cgi/content/full/218/1/101http://radiology.rsnajnls.org/cgi/content/full/218/1/101
  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    20/46

    USG

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    21/46

    Longitudinal power Doppler US image of

    the left kidney demonstrates markedly

    decreased blood flow (arrows) to the lower

    pole

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    22/46

    MRI

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    23/46

    Coronal contrast agent-enhanced fast multiplanarinversion recovery MR image (2,000-2,500/17; inversiontime, 160 msec) of the same piglet as in a demonstratesfoci (arrows) of high signal intensity in the upper and

    lower poles of the right kidney and the lower pole of theleft kidney.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    24/46

    CT Scan

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    25/46

    CT Scan

    Figure 2. Transverse spiral CT scan

    obtained after intravenous administration

    of contrast agent demonstrates well-

    defined foci (arrows) of decreasedattenuation in the anterior cortex of the

    right kidney and posterior cortex of the left

    kidney.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    26/46

    RISK FACTORS

    Obstruction (intrinsic/extrinsic)

    Urinary diversion procedures

    Foreign bodies Vesicoureteral reflux

    Neurogenic bladder

    Treatment of acute pyelonephritis in

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    27/46

    Treatment of acute pyelonephritis in

    children

    Ceftriaxone (Rocephin

    Pediatric Dose

    >7 d: 25-50 mg/kg/d IV/IM; not to exceed 125

    mg/dInfants and children: 50-75 mg/kg/d IV/IMdivided q12h; not to exceed 2 g/d

    Third-generation cephalosporin with broad-

    spectrum, gram-negative activity; lower efficacyagainst gram-positive organisms; higher efficacyagainst resistant organisms.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    28/46

    Gentamicin (Garamycin)

    Pediatric Dose

    5 years: 1.5-2.5 mg/kg/dose IV/IM q8h or

    6-7.5 mg/kg/d divided q8h; not to exceed

    300 mg/d; monitor as in adults

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    29/46

    Ampicillin (Principen, Omnipen, Marcillin)

    Pediatric Dose

    50-100 mg/kg/d PO divided q4-6h; 100-400 mg/kg/d IM/IV divided q4-6h

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    30/46

    Amoxicillin (Amoxil, Trimox

    Pediatric Dose

    20-50 mg/kg/d PO divided q8h

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    31/46

    Cephalexin (Keflex

    Pediatric Dose

    25-50 mg/kg/d PO q6h; not to exceed 3g/d

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    32/46

    Nitrofurantoin (Macrobid, Macrodantin)

    Pediatric Dose

    >1 month: 5-7 mg/kg/d PO divided q6h;not to exceed 400 mg/d

    Long-term therapy: 1-2 mg/kg/d PO

    divided 12-24 h; not to exceed 100 mg/d

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    33/46

    Trimethoprim and sulfamethoxazole

    (Bactrim, Bactrim DS, Septra, Septra DS)

    Pediatric Dose

    2 months: 15-20 mg/kg/d, based on TMP,

    PO tid/qid for 14 d

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    34/46

    Vancomycin (Vancocin

    Pediatric Dose

    40 mg/kg/d IV divided tid/qid 7-10 d

    Potent antibiotic directed against gram-positiveorganisms and active against Enterococcusspecies

    Indicated for patients who cannot receive or did

    not respond to penicillins and cephalosporins orpatients who have infections with resistantstaphylococci

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    35/46

    Patient Education

    Good hygiene (including "front-to-back"

    wiping after urination in girls)

    avoidance of bubble baths, Chemical

    irritants and tight clothing might be

    recommended.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    36/46

    Algorithm for the management of urinary tract infection in children

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    37/46

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    38/46

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    39/46

    EVIDENCE BASE MEDICINE

    A 9 month old girl presents with high fever,

    vomiting, lethargy, and bacteriologically

    confirmed urinary tract infection.

    The diagnosisacute pyelonephritis

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    40/46

    1. How should she be treated?

    2. Which antibiotics should be given and by

    which route?

    3. For how long should antibiotics be

    given?

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    41/46

    How should she be treated?

    Infants aged 1 month or less with urinary

    tract infection require intravenous

    antibiotics

    The choice of specific antibiotics should be

    based on data about local uropathogens.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    42/46

    which route?

    Two trials including 306 and 387 childrencompared oral (cefixime,amoxicillin) withintravenous (ceftriaxone) treatment for

    three days or defervescence followed bycefixime or amoxicillin. Total duration was10 or 14 days. No differences in the timeto defervescence, recurrence of urinary

    tract infection, or frequency of renalparenchymal abnormality at 6-12 monthswere evident between the two groups

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    43/46

    Which antibiotic should be given?

    trimethoprim alone or in combination with

    sulphamethoxazole, cephalexin or

    amoxicillin

    If intravenous antibiotics are required,

    aminoglycosides or third generation

    cephalosporins

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    44/46

    How long should antibiotics be given for?

    there is evidencethat short course

    treatment (3-4 days) is as effective as

    standard course (7-10 days) treatment

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    45/46

    conclusions

    These results suggest that children with

    acute pyelonephritis can be treated

    effectively with oral cefixime or with short

    courses (2-4 days) of IV therapy followed

    by oral therapy. If IV therapy is chosen,

    single daily dosing with aminoglycosides issafe and effective.

  • 7/28/2019 Acute Pyelonephritis m.arief 01-038

    46/46